Tanzeem: Mughal Iron & Steel Industries Limited MISIL
Maqam: DM Procurement
Tajaweez shudah arse: 8-10 saal
Sanad: Supply Chain mein MBA
Naukri ka Markaz: Lahore, Pakistan
Istemaal karne ki aakhri tareekh: 6th November, 2023
Tafseelat:
Tasveer mein di gayi naukri ki tafseelat ko dhyan se parhen.
Sirf tab aavedan karen agar aapki sanadain naukri ke mutabiq hain.
Maqam ki tawanaiyon se mutabiq umeedwar ko tasleem kiya jayega.
Sirf chuney gaye umeedwaron ko imtehan / interview ke liye bulaya jayega.
Ghair maqbul / adhoori darkhwasten tasleem nahi ki jayengi.
Aakhri tareekh se pehle aavedan karen.
Aakhri tareekh ke baad milti julti darkhwasten tasleem nahi ki jayengi.
Hum khushi khushi announce karte hain ke Mughal Iron & Steel Industries Limited MISIL mein
mukhtalif maqamat ke liye rozgaar ki khuli aaye hai. Agar aap apni career mein aglay qadam uthane
aur aehmi sha'waniyat qaim karna chahte hain, to yeh aapki mauqa hai! Ab manzoor shuda
umeedwaron se darkhwasten qubool ki jati hain. Yeh aapki mauqa hai ke aik dinamik team ka hissa
banen, aehmi kaam mein hissa banen aur apni career ko aage barhayen. 2023 mein behtareen tanzeem
mein shamil hone ki yeh mauqa na choren. Ab aavedan karen aur excellence ki taraf safar ka hissa
banen.
Tashheer tarikh: 10-10-2023
Tanzeem: Mughal Iron & Steel Industries Limited MISIL
Maqam: Admin Executive
Tajaweez shudah arse: 1-2 saal
Zariya: careerjaugaar.com
Sanad: Kam az kam MBA
Aakhri tareekh: 15-10-2023
Naukri ka Markaz: Quetta
Maqam Sanad Maazdoori
Admin Executive Minimum MBA 80,000.00-90,000.00
Istemaal karne se pehle zehan se parh lein:
Tasveer mein di gayi naukri ki tafseelat ko dhyan se parhen.
Sirf tab aavedan karen agar aapki sanadain maqam ke mutabiq hain.
Maqam ki tawanaiyon se mutabiq umeedwar ko tasleem kiya jayega.
Sirf chuney gaye umeedwaron ko imtehan / interview ke liye bulaya jayega.
Ghair maqbul / adhoori darkhwasten tasleem nahi ki jayengi.
Aakhri tareekh se pehle aavedan karen.
Aakhri tareekh ke baad milti julti darkhwasten tasleem nahi ki jayengi.
Rasmi Advertisement:
No comments:
Post a Comment